2024

Case #2 presented by Wesley Roberts, University of Utah, Salt Lake City, UT, USA. 2024 AIM Physician & Investigator Conference, Special Session: Multidisciplinary Interactive Tumor Board. Boston, MA. May 18 & 19, 2024.

Case #1 presented by Serine Avagyan, University of California San Francisco, San Francisco, CA, USA. 2024 AIM Physician & Investigator Conference, Special Session: Multidisciplinary Interactive Tumor Board, Boston, MA. May 18 & 19, 2024

“Advanced Systemic Mastocytosis” presented by Tsewang Tashi, MD, University of Utah, Salt Lake City, UT, USA. 2024 AIM Physician & Investigator Conference, Session 5: Therapies, Novel Agents, & Survival, Boston, MA. May 18& 19, 2024.

“Management of Unusual Cases in Pediatric-Onset Mastocytosis” presented by Melody Carter, MD, National Institutes of Health, Bethesda, MD, USA. 2024 AIM Physician & Investigator Conference, Boston, MA. May 18 & 19, 2024.

Session 2: Pathology & Molecular Biology Discussion Panel w. Q&A. Moderated by Olga Pozdnyakova, University of Pennsylvania and Andreas Reiter, University Hospital Mannheim. Panelists: Peng Li, ARUP Laboratories, Alberto Orfao, University of Salamanca, Irina Maric, National Institutes of Health, Tracy George, ARUP Laboratories. 2024 AIM Physician & Investigator Conference, Boston, MA. May 18 & 19,

Session 1: Research Updates in Mast Cell Biology, Discussion Panel w. Q&A. Moderated by, Gregor Hoermann, Munich Leukemia Laboratory and Michael Deininger, Versiti Blood Research Institute. Panelists, Karin Hartmann, University of Basel, Dan Dwyer, Brigham & Women’s Hospital/ Harvard University, Joshua Boyce, Brigham & Women’s Hospital/ Harvard University, and Gregor Hoermann, Munich Leukemia Laboratory. 2024

“Indolent Systemic Mastocytosis: Targeted Versus Symptomatic Treatment Approach”, presented by Thanai Pongdee, MD, Mayo Clinic, Rochester, MN, USA. 2024 AIM Physician & Investigator Conference, Session 5: Therapies, Novel Agents, & Survival. Boston, MA. May 18 & 19, 2024.

“Decreased Survival Among Patients with Indolent Systemic Mastocytosis” presented by Sudipto Mukherjee, MD, PhD, Cleveland Clinic, Cleveland, OH, USA. 2024 AIM Physician & Investigator Conference, Session 5: Therapies, Novel Agents, and Survival. Boston, MA. May 18 & 19, 2024.

“Brain Impact in Mastocytosis” presented by Jennifer Nicoloro-SantaBarbara, PhD, Brigham & Women’s Hospital/ Harvard University, Boston, MA, USA. 2024 AIM Physician & Investigator Conference, Session 4: Clinical Heterogeneity in Mast Cell Disease, Boston, MA. May 18 & 19, 2024.